From data to insights to decisions

GPI is a team of pricing, market access, and commercial strategy experts, solving our biopharma clients’ greatest challenges by harnessing the power of technology, data, and collective experience.

Whether it is through our platform, GPI pulse™, or through our bespoke strategy engagements, we are here to support you.

  • >6Mil

    rows of drug pricing

  • >5K

    ATCs

  • 90+

    global pricing markets

  • 25

    HTA markets

Bringing efficiency to your strategies

GPI is leading the way to a future where effective business strategies are rooted in data-derived insights. Through thoughtful analytics and creative methodologies, we provide the tools and insights biopharma needs to make critical decisions.

Unlock the power of integrated data with GPI pulse™

GPI pulse™ is your trusted value, price, and access intelligence platform. We leverage the latest technology to combine multiple data streams in a way that will give you unique insight into the full biopharma market access journey.

Demystifying price and value with GPI Horizon methodology

Take an unconventional approach rooted in quantified payer behaviour and robust data analysis. Using our novel methodology, GPI Horizon, we decode payer thinking to forecast the perceived value and price potential of your asset.

Therapy area expertise leveraging GPI Horizon Methodology
Oncology
Orphan and Rare
Specialty Medicines
We strive to make our clients shine

GPI brings an extensive network of experts to support our international pricing needs. Their hard work and service are an invaluable attribute to our team.

Global Pricing Innovations is exactly the kind of company we were looking for. GPI provides us with best-in-class operational pricing and market access support to help grow our business.

GPI’s commitment to quality is outstanding. The group has a great geographic reach with an impressive understanding of pricing systems worldwide including connections to local market experts.

Highly knowledgeable team, faster, detailed and relevant responses compared to previous suppliers.

Indication specific data is more superior than currently available solutions, no one else is providing this level of granularity.